Also categorized in BoardMoves:
Time Inc. Appoints Griffin CEO
x hide permanently

ADMA Biologics Announces Martha J. Demski Elected to Board of Directors


ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today announced that the proposed resolution to elect Martha J. Demski to its Board of Directors was approved at the Company’s recent Annual Shareholder Meeting, held June 18, 2020...

Mentions: Nasdaq Adamas Bank